Weekly Signal Report — November 14, 2026

📉 22 crossed below 📈 31 recovered

This week, 22 stocks crossed below their 200-week moving average — entering what we call “deep value territory.” This is the signal our screener is built to detect: quality companies trading below a price level that has historically represented a floor over the prior four years.

Not every stock that crosses the line is a buy. Some are cheap for good reason. The 200-week moving average is a starting point for research, not a buy signal. Below, we break down each new crossing with the context you need to decide whether it’s opportunity or a warning.

On the other side, 31 stocks climbed back above the line this week — exiting deep value territory.

What is deep value territory?

The 200-week moving average represents roughly four years of price history. When a stock drops below this level, it means the current price is lower than the average investor paid over the last four years. For quality companies, these moments are rare — most stocks only cross below the 200-week line a handful of times in their history.

Our data shows that while 12-month returns from a crossing can be modest, 24-month returns are often significantly higher. The strategy requires patience. Not every crossing is a buying opportunity — some stocks are cheap because the business is deteriorating. That's why we pair the signal with quality metrics like free cash flow trends, insider buying, and return on equity.

📉 Newly Below the Line

MPAA — Motorcar Parts of America, Inc.

Consumer Cyclical - Auto Parts $145M
21% below $7.62 → 200WMA $9.65

Historical Context

This is the 18th time MPAA has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -14.1%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

📉 RSI 12 (Oversold) 🔄 Frequent Crosser — Weak Recoveries 💥 Capitulation Volume

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Oversold (RSI 12): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • Cycling pattern: MPAA has crossed below the 200-week MA 18 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full MPAA analysis →

HIMS — Hims & Hers Health, Inc.

Healthcare - Telehealth & Wellness $4.6B
19% below $19.73 → 200WMA $24.35

Historical Context

This is the 8th time HIMS has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +6.7%. History favors the patient buyer here.

Quality Signals

🔍 Insider Buying 💰 12.4% FCF Yield 💥 Capitulation Volume

Things to Watch

  • Cycling pattern: HIMS has crossed below the 200-week MA 8 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full HIMS analysis →

GRPN — Groupon, Inc.

Communication Services - Internet Content & Information $496M
17.6% below $12.41 → 200WMA $15.07

Historical Context

This is the 8th time GRPN has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -3.4%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

📉 RSI 14 (Oversold) 🔄 Frequent Crosser — Weak Recoveries 💥 Capitulation Volume

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Oversold (RSI 14): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • Cycling pattern: GRPN has crossed below the 200-week MA 8 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full GRPN analysis →

CURLF — Curaleaf Holdings Inc.

Healthcare - Cannabis $2.1B
13% below $7.85 → 200WMA $9.02

Historical Context

This is the 4th time CURLF has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +0.1%. History favors the patient buyer here.

Quality Signals

🔄 Frequent Crosser — Weak Recoveries

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cycling pattern: CURLF has crossed below the 200-week MA 4 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full CURLF analysis →

FSLR — First Solar Inc.

Technology - Solar $18.4B
12.5% below $171.39 → 200WMA $195.82

Historical Context

This is the 22th time FSLR has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +27.3%. History favors the patient buyer here.

Quality Signals

🏆 Buffett Quality 📉 RSI 24 (Oversold)

Things to Watch

  • Oversold (RSI 24): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full FSLR analysis →

QUBT — Quantum Computing Inc.

Technology - Quantum Computing $1.3B
10.5% below $5.56 → 200WMA $6.21

Historical Context

This is the 11th time QUBT has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +445.1%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining 📉 RSI 20 (Oversold)

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Oversold (RSI 20): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full QUBT analysis →

BABA — Alibaba Group Holding Limited

Consumer Discretionary - E-Commerce $234.8B
9% below $94.38 → 200WMA $103.70

Historical Context

This is the 4th time BABA has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -9.2%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

⚠️ FCF Declining 📉 RSI 28 (Oversold) 🔄 Frequent Crosser — Weak Recoveries

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Oversold (RSI 28): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: BABA has crossed below the 200-week MA 4 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full BABA analysis →

IREN — Iris Energy Limited

Technology - Bitcoin Mining $7.7B
4.7% below $18.17 → 200WMA $19.07

Historical Context

This is the 7th time IREN has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +157.2%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining 📉 RSI 28 (Oversold)

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Oversold (RSI 28): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full IREN analysis →

GPN — Global Payments Inc.

Industrials - Specialty Business Services $24.3B
4% below $91.90 → 200WMA $95.78

Historical Context

This is the 18th time GPN has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +20.1%. History favors the patient buyer here.

Quality Signals

🔍 Insider Buying 📈 FCF Growing 💰 30.7% FCF Yield

Things to Watch

  • RSI still elevated (56): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full GPN analysis →

VERA — Vera Therapeutics, Inc.

Healthcare - Biotechnology $2.0B
3.6% below $28.10 → 200WMA $29.15

Historical Context

This is the 8th time VERA has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +70.9%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full VERA analysis →

DNN — Denison Mines Corp.

Energy - Uranium $1.9B
3.1% below $2.06 → 200WMA $2.13

Historical Context

This is the 17th time DNN has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +7.7%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining 📉 RSI 19 (Oversold)

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Oversold (RSI 19): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: DNN has crossed below the 200-week MA 17 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full DNN analysis →

EVTC — EVERTEC, Inc.

Technology - Software - Infrastructure $1.9B
2.5% below $32.54 → 200WMA $33.37

Historical Context

This is the 14th time EVTC has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +7.9%. History favors the patient buyer here.

Quality Signals

💰 9.4% FCF Yield ⚠️ FCF Declining

Things to Watch

  • RSI still elevated (58): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: EVTC has crossed below the 200-week MA 14 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full EVTC analysis →

YETI — YETI Holdings, Inc.

Consumer Discretionary - Outdoor Products $2.9B
1.9% below $39.42 → 200WMA $40.17

Historical Context

This is the 5th time YETI has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +61%. History favors the patient buyer here.

Quality Signals

🏆 Buffett Quality 📉 RSI 27 (Oversold) 💥 Capitulation Volume

Things to Watch

  • Oversold (RSI 27): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full YETI analysis →

RCUS — Arcus Biosciences, Inc.

Healthcare - Oncology $2.5B
1.8% below $17.43 → 200WMA $17.76

Historical Context

This is the 5th time RCUS has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +71.5%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining 📉 RSI 17 (Oversold)

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Oversold (RSI 17): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full RCUS analysis →

MCD — McDonald's Corporation

Consumer Discretionary - Restaurants $192.0B
1.3% below $271.97 → 200WMA $275.57

Historical Context

This is the 30th time MCD has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +3%. History favors the patient buyer here.

Quality Signals

👑 Dividend Aristocrat 📈 FCF Growing 🔄 Frequent Crosser — Weak Recoveries

Things to Watch

  • Cycling pattern: MCD has crossed below the 200-week MA 30 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full MCD analysis →

ACB — Aurora Cannabis Inc.

Healthcare - Cannabis $325M
1.1% below $4.94 → 200WMA $5.00

Historical Context

This is the second time ACB has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +73.8%. History favors the patient buyer here.

Quality Signals

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • RSI still elevated (71): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full ACB analysis →

UMH — UMH Properties, Inc.

Real Estate - Manufactured Housing $1.2B
1.1% below $14.55 → 200WMA $14.71

Historical Context

This is the 19th time UMH has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +16.2%. History favors the patient buyer here.

Quality Signals

🎯 Yartseva Multibagger 💰 5.3% FCF Yield

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full UMH analysis →

MSEX — Middlesex Water Company

Utilities - Utilities - Regulated Water $1.1B
1% below $57.40 → 200WMA $58.00

Historical Context

This is the 22th time MSEX has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +5.9%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: MSEX has crossed below the 200-week MA 22 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full MSEX analysis →

CERS — Cerus Corporation

Healthcare - Medical Devices $401M
1% below $1.99 → 200WMA $2.00

Historical Context

This is the 28th time CERS has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +12.9%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full CERS analysis →

CEVA — CEVA, Inc.

Technology - Semiconductors $730M
0.5% below $25.59 → 200WMA $25.73

Historical Context

This is the 24th time CEVA has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +16.1%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full CEVA analysis →

MUX — McEwen Inc.

Basic Materials - Other Precious Metals & Mining $733M
0.3% below $11.90 → 200WMA $11.93

Historical Context

This is the 39th time MUX has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +38.5%. History favors the patient buyer here.

Quality Signals

📉 RSI 25 (Oversold) 💥 Capitulation Volume

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Oversold (RSI 25): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full MUX analysis →

YMM — Full Truck Alliance Co. Ltd.

Technology - Freight Marketplace $9.1B
0.1% below $8.69 → 200WMA $8.70

Historical Context

This is the 7th time YMM has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +29.7%. History favors the patient buyer here.

Quality Signals

💰 66.2% FCF Yield

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full YMM analysis →

📈 Recovered Above the Line

These stocks climbed back above their 200-week moving average this week. If you bought during their time below the line, this is a milestone — though not necessarily a sell signal.

the flagship work

Latest Deep Dives

HIMS Hims & Hers (HIMS): Revenue Up 49%, Gross Profit Per Member Stuck Near $60 +0.0% since publish GENI GENI Q2 Review: What the Screener Found, and What the Business Proved -17.5% since publish GENI Genius Sports (GENI): The Operating System of Modern Sport +7.4% since publish All deep dives →

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.